Scancell
Cancer treatment development company
- B2B
About Scancell
Developing 'off-the-shelf' vaccines and tumour-specific monoclonal antibodies. These advanced therapeutic programs show promising efficacy in trials for metastatic melanoma and solid tumours.
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Oxford, England, United Kingdom
- Revenue
- $11.5M – $90.6MTamtam estimate
- Website
- scancell.co.uk
Scancell at a glance
Scancell is a B2B company in the Biotechnology Research industry, headquartered in Oxford, England, United Kingdom.
Scancell has 51–250 employees.
Scancell's revenue is $11.5M – $90.6M (Tamtam estimate).
Selling to companies like Scancell?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies